Invasive Fungal Infections: Current and Emerging Strategies Toward Improved Outcomes Pre-Activity Survey Question Title * 1. I am: Infectious Disease physician Internist Nurse Clinical pharmacist Clinical microbiologist Other (please specify) Epidemiology Question Title * 2. Which of the following do you consider to be the most problematic fungal pathogen at your institution? Candida albicans Other Candida spp. Aspergillus Other molds None of the above Question Title * 3. In your practice, how often do you encounter Candida isolates that exhibit resistance to azole therapy? Frequently Sometimes Rarely Never Question Title * 4. At your institution, first-line treatment for a patient with neutropenic fever (>72 hours) and with a suspected Candida infection is: Fluconazole A broad-spectrum azole An echinocandin A polyene Nothing until the infection is confirmed Diagnostics Question Title * 5. A diagnostic test to differentiate among Candida species from blood culture is: Beta-D-glucan PNA-FISH Galactomannan Question Title * 6. At your institution, when an IFI is suspected, how much time typically passes before antifungal treatment is initiated? <12 hours 12-24 hours 1-2 days 2-4 days >4 days Not sure Question Title * 7. When invasive candidiasis is confirmed, how often do you request for susceptibility testing? Always Frequently Sometimes Rarely Never Prophylaxis Question Title * 8. How often do you utilize IDSA guidelines when selecting antifungal prophylaxis for at-risk patients? Always Frequently Sometimes Rarely Never Question Title * 9. When selecting antifungal prophylaxis, I consider the local epidemiology when choosing the agent? True False Question Title * 10. The most common antifungal agent used for prophylaxis at your institution is: Fluconazole Broad-spectrum azole Echinocandin Polyene Treatment Question Title * 11. At your institution, how often is combination antifungal therapy used for empiric treatment of invasive fungal infections? Frequently Sometimes Rarely Never Question Title * 12. How often do you utilize IDSA guidelines when selecting treatment for candidiasis or aspergillosis? Always Frequently Sometimes Never Question Title * 13. Which of the following present significant challenges to you when treating an IFI? (check all that apply) Selecting an effective agent Resistance to antifungal agents Appropriate dosing Timely diagnosis Managing adverse effects of antifungals Drug-drug interactions Determining duration of therapy Other (please specify) Done